Belgian diagnosis firm Biocartis plans listing

April 1, 2015 6:47 AM

2 0

BRUSSELS, April 1 (Reuters) - Belgian molecular diagnosis company Biocartis Group NV announced on Wednesday that it planned to float on Euronext Brussels, using the proceeds to expand its range of tests and increase its sales and marketing teams.

The company, based in the Belgian town of Mechelen, employs about 200 people and launched its testing system, known as Idylla, in September 2014. It can give results from a sample in between 40 and 150 minutes.

Also read: Rate Increases for Health Plans Pose Serious Test for Obama’s Signature Law

Read more

To category page